August 12, 2025 Bayer and Kumquat Biosciences Enter Global Exclusive License and Collaboration in Precision Oncology Read More April 16, 2024 Kumquat Biosciences and Takeda Enter into Strategic Collaboration and Exclusive Global License Agreement to Advance Novel Oral Immuno-Oncology Drug Candidate Read More July 29, 2021 Lilly and Kumquat Biosciences Announce Collaboration to Discover and Develop Novel Small Molecules that Stimulate Tumor-Specific Immune Responses Read More
